Randomized Phase III Trial of Atezolizumab + Bevacizumab The combination therapy proved efficacious, progression-free survival by PD-L1 group - 101950

Spotlight
Video

Randomized Phase III Trial of Atezolizumab + Bevacizumab The combination therapy proved efficacious, progression-free survival by PD-L1 group

Loading........
Description: Aly-Khan Lalani, MD from Dana-Farber Cancer Institute discusses the Randomized Phase III Trial of Atezolizumab + Bevacizumab The combination therapy proved efficacious, progression-free survival by PD-L1 group at the 2018 ASCO.
Shared By : Genitourinary-Cancer-Meeting
Posted on : 02/15/18
Added : 9 months ago
Category : Kidney Cancer



Recommended

Nothing found.